Ultragenyx Pharmaceutical Inc at Cowen Health Care Conference- Orphan CNS Panel Discussion Transcript
(technical difficulty) Annual TD Cowen 43rd Conference. It's my pleasure today to co-moderate the orphan neurology Corporate panel with my colleague, Anvita Gupta and joined by esteemed panel of industry titans here. We have one swap out, Gary Romano, CMO of Alector; we also have Essra Ridha, the CMO of AVROBIO; Ryan Watts, CEO of Denali Therapeutics; Bobby Gaspar, CEO of Orchard Therapeutics; William Chou, the CEO of Passage Bio; and Emil Kakkis, the President and CEO of Ultragenyx.
So most of you are probably familiar with the general format at this point, but we're going to pitch a few thematic questions on the orphan neurology space, so the panel is kind of split it up between them, and then we'll kind of dive into some company-specific questions and more of round-robin later on. So with that said, let's dive right in.
Questions & Answers
So obviously, a lot going on orphan neurology space, the breadth of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
